Insulin Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,UK,Germany,China,Japan - Size and Forecast 2023-2027

Published: Dec 2022 Pages: 154 SKU: IRTNTR74807

Insulin Market Forecast 2023-2027

The global insulin market size is estimated to grow by USD 1,662.41 million between 2022 and 2027 accelerating at a CAGR of 1.77%. 

The growth of the market share depends on several factors, including the growing prevalence of diabetes, the increasing exposure to risk factors that lead to diabetes, the favorable government initiatives.

Insulin Market Forecast and Analysis

 View the Bestselling Market Research Sample 

Market Dynamics

Our researchers analyzed the data with 2022 as the base year, along with the key drivers, market trends and analysis, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Driver

Diabetes is a chronic disease caused by the body's inability to use insulin effectively or when the pancreas does not produce enough insulin, leading to hyperglycemia. The prevalence of diabetes is rising, and the number of diabetic patients worldwide is projected to double in the next 25 years. In 2021, around 537 million adults in the age group of 20-79 years were living with diabetes, and this number is estimated to reach 643 million by 2030 and 783 million by 2045. Diabetes resulted in 6.7 million deaths globally. The growing prevalence of diabetes will significantly increase healthcare costs for patients and governments. Obesity, smoking, a sedentary lifestyle, growing urbanization, and an aging population are factors contributing to the increase in the population with diabetes. The increasing incidence of diabetes is likely to drive the growth of the market during the forecast period.

Significant Trends

The global market is experiencing significant technological advancements in high-tech insulin delivery devices. The traditional invasive methods are being replaced by non-invasive ones, which reduce pain and improve patient experience. Insulin inhalers, insulin infusion pumps, mouth sprays, and insulin patches are some examples of these innovative devices. These devices offer flexibility, accuracy, and convenience in delivery, thereby enhancing the quality of life for diabetic patients. The market demand for these devices is growing, which is driving vendors to design more innovative, discreet, and efficient devices. This trend is expected to contribute significantly to the growth of the market.

Major Market Challenge

Improving medical device regulations is crucial to ensure the delivery of safe and efficient technologies to end-users. However, the increasing number and advancements in medical devices have created new regulatory challenges. The regulatory networks in Europe and the US are particularly stringent, and companies face multiple hurdles to ensure patient safety and efficient devices' market launch. Insulin and its delivery devices are categorized as Class II Medical Devices by the US FDA and must comply with their regulations before release. Failure to do so or complications arising from their use could result in a product recall, which would negatively impact the company's brand reputation. Europe's regulatory process is faster than the US FDA, focusing on strengthening post-market regulations, robust surveillance systems, and improving product monitoring. The strict regulatory scenario may hinder the growth of the global market, and companies focusing on innovative technologies and novel products must undergo stringent post-market approvals before launch.

Who are the Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

CODAN Medizinische Gerate GmbH and Co KG - The company offers medical equipment such as infusion sets, transfusion sets, and pediatric products. The key offerings of the company include insulin.

The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market players, including:

  • AdvaCare Pharma
  • ASP Healthcare Pty Ltd.
  • B. Braun SE
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Cardinal Health Inc.
  • Eli Lilly and Co.
  • Gerresheimer AG
  • Gulf Pharmaceutical Industries
  • Healthwarehouse.com Inc.
  • Hindustan Syringes and Medical Devices Ltd.
  • Hi Tech Medics Pvt Ltd.
  • Mayo Foundation for Medical Education and Research
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA
  • UltiMed Inc.
  • Wockhardt Ltd.
  • Nipro Corp.

Technavio’s report consists of a holistic analysis of the key development analysis,  development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.  

Market Segmentation by Type, Distribution Channel, Geography

Type Analysis

The market share growth by the insulin analogs segment will be significant during the forecast period. These analogs are synthetically produced, modified forms of insulin. Altering insulin analogs alters the rate at which the body absorbs insulin. Several studies have found a reduced risk of hypoglycemia and a slight reduction in nocturnal hypoglycemia that is associated with basal insulin. Another study found fewer nocturnal and severe hypoglycemic events and better glycemic control associated with fast-acting insulin when compared with regular human insulin. These benefits of analog insulin are more pronounced in patients with type 1 diabetes, especially those at high risk of hypoglycemia. These benefits are anticipated to boost the growth of this insulin segment.

Get a detailed analysis of various segments View Sample PDF 

Distribution Channel Analysis

Retail pharmacists (often known as community pharmacists) sell medicines and medical-related products, as well as other goods, such as toiletries, cosmetics, and veterinary products, to the general public and medical practitioners. Retail pharmacies are independent pharmacies, or chain pharmacies, which are licensed as a pharmacy by the State and dispense medications to the general public at retail prices. These pharmacies are typically located across residential areas to ensure easy access to medicines. In comparison with hospitals and online pharmacies, retail pharmacies have a higher market share due to their reliability and convenience. The aforementioned factors are driving the market growth.

Geographical Analysis

For more insights on the market share of various regions View PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The increasing prevalence of diabetes and the rising number of overweight and obese people are some of the major factors driving the market growth of the regional market. The risk of dying from cardiovascular disease (CVD) and other related comorbidities is 2-3 times higher among people with diabetes. This leads to the increased usage of diabetes care products such as insulin.

Increased awareness among the population about diabetes and its wide-ranging consequences on health has resulted in most people in the US opting to undergo regular tests and check-ups, which has increased the sale in the country. Also, the country is the base for several leading vendors in the market. Other factors, such as new technology that provides continuous monitoring of glucose levels and increasing US FDA approvals for new products, are driving the market growth in the region.

Additionally, favorable reimbursement policies have led to the high adoption of insulin in North American countries. For instance, Medicare and Medicaid in the US provide reimbursement fees on patient hospital visits for the treatment of many ailments. The monetary support from the government for public healthcare is estimated to ensure better access to insulin. This will contribute to the regional market growth during the forecast period.

Market Analyst Overview

The market is a critical segment of healthcare, particularly for the diabetic population, with a focus on improving blood sugar control. Various types of insulin, including long-acting insulin like Lantus, Humulin, and Humalog, are available, offering options for drug delivery and dosing regimens. The market also sees the entry of generic competitors, providing more affordable alternatives. Novel formulations like Insulin Tregopil aim to improve compliance and efficacy. The market's growth is fueled by factors such as the increasing prevalence of diabetes, especially in developing countries, and the rising adoption of insulin therapy. Manufacturing and supply chain efficiency are crucial to meet the demand. Regulatory bodies like the Drugs Controller General of India ensure the quality and safety of insulin products. Health insurance coverage plays a significant role in patients' access to these medications. Overall, the insulin market is driven by innovation, accessibility, and adherence to treatment protocols, contributing to better health outcomes for diabetic individuals.

Market Scope

Report Coverage

Details

Page number

120

Base year

2022

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 1.77%

Market growth 2023-2027

USD 1,662.41 million

Market structure

Fragmented

YoY growth (%)

1.34

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key consumer countries

US, UK, Germany, China, and Japan

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corp.

Market dynamics

Parent market analysis, Market forecasting, market growth and forecasting inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market growth analysis for forecast period

Customization purview

If our market research report does not include the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF sample

What are the Key Data Covered in this Market Report?

  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will drive market growth during the next five years
  • Precise estimation of the market size and its contribution to the parent market
  • Accurate predictions on market growth and trends and changes in consumer behavior
  • The growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of market research and growth of the market’s competitive landscape and detailed information on companies
  • Comprehensive market analysis and report on the factors that will challenge the growth of market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global insulin market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global insulin market 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 Distibution channel Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Distibution channel Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Insulin analog - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Insulin analog - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Insulin analog - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Insulin analog - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Insulin analog - Year-over-year growth 2022-2027 (%)
    • 6.4 Human insulin - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 43: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 45: Chart on Comparison by Distribution Channel
      • Exhibit 46: Data Table on Comparison by Distribution Channel
    • 7.3 Retail pharmacies - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
    • 7.4 Hospitals - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 7.5 Online pharmacies - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Distribution Channel
      • Exhibit 59: Market opportunity by Distribution Channel ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 101: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 104: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 105: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 106: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 107: Matrix on vendor position and classification
            • 12.3 B. Braun SE
              • Exhibit 108: B. Braun SE - Overview
              • Exhibit 109: B. Braun SE - Business segments
              • Exhibit 110: B. Braun SE - Key news
              • Exhibit 111: B. Braun SE - Key offerings
              • Exhibit 112: B. Braun SE - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 113: Becton Dickinson and Co. - Overview
              • Exhibit 114: Becton Dickinson and Co. - Business segments
              • Exhibit 115: Becton Dickinson and Co. - Key news
              • Exhibit 116: Becton Dickinson and Co. - Key offerings
              • Exhibit 117: Becton Dickinson and Co. - Segment focus
            • 12.5 Biocon Ltd.
              • Exhibit 118: Biocon Ltd. - Overview
              • Exhibit 119: Biocon Ltd. - Business segments
              • Exhibit 120: Biocon Ltd. - Key offerings
              • Exhibit 121: Biocon Ltd. - Segment focus
            • 12.6 Cardinal Health Inc.
              • Exhibit 122: Cardinal Health Inc. - Overview
              • Exhibit 123: Cardinal Health Inc. - Business segments
              • Exhibit 124: Cardinal Health Inc. - Key news
              • Exhibit 125: Cardinal Health Inc. - Key offerings
              • Exhibit 126: Cardinal Health Inc. - Segment focus
            • 12.7 CODAN Medizinische Gerate GmbH and Co KG
              • Exhibit 127: CODAN Medizinische Gerate GmbH and Co KG - Overview
              • Exhibit 128: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
              • Exhibit 129: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
            • 12.8 Eli Lilly and Co.
              • Exhibit 130: Eli Lilly and Co. - Overview
              • Exhibit 131: Eli Lilly and Co. - Product / Service
              • Exhibit 132: Eli Lilly and Co. - Key offerings
            • 12.9 Gerresheimer AG
              • Exhibit 133: Gerresheimer AG - Overview
              • Exhibit 134: Gerresheimer AG - Business segments
              • Exhibit 135: Gerresheimer AG - Key news
              • Exhibit 136: Gerresheimer AG - Key offerings
              • Exhibit 137: Gerresheimer AG - Segment focus
            • 12.10 Gulf Pharmaceutical Industries
              • Exhibit 138: Gulf Pharmaceutical Industries - Overview
              • Exhibit 139: Gulf Pharmaceutical Industries - Product / Service
              • Exhibit 140: Gulf Pharmaceutical Industries - Key offerings
            • 12.11 Hindustan Syringes and Medical Devices Ltd.
              • Exhibit 141: Hindustan Syringes and Medical Devices Ltd. - Overview
              • Exhibit 142: Hindustan Syringes and Medical Devices Ltd. - Product / Service
              • Exhibit 143: Hindustan Syringes and Medical Devices Ltd. - Key offerings
            • 12.12 Mayo Foundation for Medical Education and Research
              • Exhibit 144: Mayo Foundation for Medical Education and Research - Overview
              • Exhibit 145: Mayo Foundation for Medical Education and Research - Product / Service
              • Exhibit 146: Mayo Foundation for Medical Education and Research - Key offerings
            • 12.13 Nipro Corp.
              • Exhibit 147: Nipro Corp. - Overview
              • Exhibit 148: Nipro Corp. - Business segments
              • Exhibit 149: Nipro Corp. - Key offerings
              • Exhibit 150: Nipro Corp. - Segment focus
            • 12.14 Novo Nordisk AS
              • Exhibit 151: Novo Nordisk AS - Overview
              • Exhibit 152: Novo Nordisk AS - Business segments
              • Exhibit 153: Novo Nordisk AS - Key offerings
              • Exhibit 154: Novo Nordisk AS - Segment focus
            • 12.15 Pfizer Inc.
              • Exhibit 155: Pfizer Inc. - Overview
              • Exhibit 156: Pfizer Inc. - Product / Service
              • Exhibit 157: Pfizer Inc. - Key news
              • Exhibit 158: Pfizer Inc. - Key offerings
            • 12.16 Sanofi SA
              • Exhibit 159: Sanofi SA - Overview
              • Exhibit 160: Sanofi SA - Business segments
              • Exhibit 161: Sanofi SA - Key news
              • Exhibit 162: Sanofi SA - Key offerings
              • Exhibit 163: Sanofi SA - Segment focus
            • 12.17 Wockhardt Ltd.
              • Exhibit 164: Wockhardt Ltd. - Overview
              • Exhibit 165: Wockhardt Ltd. - Business segments
              • Exhibit 166: Wockhardt Ltd. - Key offerings
              • Exhibit 167: Wockhardt Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              insulin market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis